Protein Assay Kits Sales

Protein Assay Kits Sales Market Outlook

The global Protein Assay Kits market is projected to reach approximately USD 5 billion by 2035, growing at a compound annual growth rate (CAGR) of around 7.5% during the forecast period from 2025 to 2035. This growth can be attributed to the increasing prevalence of diseases requiring precise protein measurement for diagnosis and treatment, rising investment in life sciences research, and the expanding biopharmaceutical industry. Furthermore, advancements in technology leading to more efficient and accurate protein analysis methods are anticipated to boost market demand. Growing awareness about personalized medicine and the need for drug discovery and development are additional factors that are expected to drive the market forward. Additionally, the rise in biomarker research and the growing focus on preclinical and clinical research will create further opportunities in the protein assay kits market.

Growth Factor of the Market

One of the primary growth factors driving the Protein Assay Kits market is the escalating demand for accurate diagnostic tools that can be used in various research and clinical applications. As healthcare providers increasingly rely on precise biomarker identification and quantification to enhance patient outcomes, the need for effective protein assay kits has surged. Moreover, the rise in chronic diseases, such as cancer, diabetes, and cardiovascular disorders, has led to an increased focus on early diagnosis and targeted treatment strategies, further propelling the demand for robust protein assays. The integration of advanced technologies, such as high-throughput screening and automation, into protein assay processes has not only improved the efficiency of these kits but has also resulted in significant cost reductions, making them more accessible to researchers. Furthermore, the growing trend of personalized medicine, aiming to tailor treatments based on individual patient profiles, has further accentuated the necessity for reliable protein analysis tools. Lastly, the upsurge in funding allocated to biotechnology and pharmaceutical research will continue to stimulate innovations in protein assay development, thus enhancing the market's growth trajectory.

Key Highlights of the Market

• The global Protein Assay Kits market is expected to witness a steady CAGR of 7.5% from 2025 to 2035.
• North America is anticipated to dominate the market, accounting for approximately 40% of the total share.
• The rise in chronic diseases and the need for precise diagnostics have significantly bolstered market growth.
• Advancements in technology and automation are driving innovations in protein assay development.
• The increasing investment in life sciences research and drug development is expected to create ample market opportunities.

By Product Type

Dye-binding Assay Kits:

Dye-binding assay kits are among the most commonly utilized protein assay tools in laboratories. They operate on the principle of proteins binding to specific dyes, with the intensity of the resulting color correlating to the protein concentration in the sample. These kits are favored for their simplicity and rapid results, making them suitable for various applications ranging from academic research to clinical diagnostics. Additionally, the dye-binding method is particularly effective for determining the concentration of proteins in complex biological samples such as serum or plasma. The demand for dye-binding kits has been consistent owing to their cost-effectiveness and ease of use, especially in educational settings and smaller laboratories with limited resources.

Copper-Ion Based Assay Kits:

Copper-ion based assay kits have gained traction in the protein assay market due to their reliability and sensitivity. Utilizing the biuret reaction, these kits allow for the quantification of proteins based on the formation of a colored complex when proteins react with copper ions in an alkaline solution. These kits are particularly notable for their applicability in determining total protein content in samples, which is crucial for numerous biochemical experiments. The increasing adoption of these kits in both research and clinical laboratories can be attributed to their robustness and compatibility with various sample types, including tissues and cell lysates. Their growing importance in protein characterization and profiling further emphasizes their relevance in the protein assay kits market.

Test Strip/ Dipstick Assay Kits:

Test strip or dipstick assay kits represent a convenient and user-friendly approach to protein analysis, especially in point-of-care settings. These kits employ a simple format where a sample is applied to a strip that contains specific reagents which react with the target protein, yielding a visual result. Their ease of use and rapid turnaround time make them particularly appealing for clinical diagnostics and screening applications. The rising demand for quick and portable diagnostic solutions is propelling the growth of this segment, especially in developing regions where laboratory facilities may be limited. Furthermore, advancements in test strip technology are enhancing the sensitivity and specificity of these assays, further driving their adoption in various healthcare settings.

Colorimetric Assay Kits:

Colorimetric assay kits are widely utilized for protein quantification due to their accuracy and ease of interpretation. These kits rely on color changes in response to protein interactions with specific reagents, providing quantitative results that are easy to measure using spectrophotometry. The versatility of colorimetric assays allows them to be used across different applications, including protein purification, enzyme activity assays, and monitoring protein interactions. The market for colorimetric assay kits is expected to grow significantly, driven by their extensive application in both research and diagnostic laboratories. Furthermore, the increasing focus on quality control in biopharmaceutical manufacturing is likely to enhance the demand for these robust assay kits.

Fluorescence-based Assay Kits:

Fluorescence-based assay kits are at the forefront of modern protein analysis, offering exceptional sensitivity and specificity. These kits utilize fluorescent dyes or labels that emit light when excited, allowing for the detection of proteins at lower concentrations compared to traditional methods. Their application spans various fields, including drug discovery, molecular biology, and clinical diagnostics, where precise quantification of proteins is essential. The rise in personalized medicine, coupled with advances in fluorescence technology, is anticipated to bolster the growth of this segment in the coming years. Furthermore, the integration of fluorescence-based assays with high-throughput screening platforms is expected to enhance their utility in large-scale studies, thereby driving their adoption in laboratories worldwide.

By Application

Drug Discovery & Development:

The application of protein assay kits in drug discovery and development is significant, as they provide critical insights into the interactions between potential drug compounds and their targets. Protein quantification is essential in assessing the efficacy and potency of new therapeutic agents, making these kits indispensable in the research process. The increasing investment in pharmaceutical research and the push for novel drug development due to rising healthcare challenges are propelling the demand for protein assays in this domain. Additionally, collaborations between pharmaceutical companies and research institutes are expected to further enhance the utilization of protein assay kits in this application area, driving growth in the market.

Disease Diagnosis:

Protein assay kits play a crucial role in the diagnosis of various diseases, particularly those related to protein dysfunction or abnormalities. The ability to quantify specific proteins can aid in the identification of biomarkers associated with conditions such as cancer, cardiovascular diseases, and inflammatory disorders. As healthcare providers increasingly prioritize early diagnosis and preventive care, the demand for reliable protein assays for routine screening and diagnostics is expected to grow. The rising prevalence of chronic diseases and the associated need for effective monitoring tools will further contribute to the expansion of this application segment within the protein assay kits market.

Protein Purification:

Protein purification is another critical application of protein assay kits, particularly in research and biotechnology. Accurate quantification of proteins is necessary to determine purity levels and assess the yield from purification processes. These assays are essential for researchers aiming to isolate specific proteins for downstream applications, including structural biology studies, functional assays, and therapeutic development. The growing interest in proteomics and the exploration of novel protein-based therapeutics are key factors driving the demand for protein purification assays. As the field of biotechnology continues to evolve, the need for precise protein quantification will remain a pivotal aspect of protein research.

Others:

This category encompasses a diverse range of applications where protein assay kits are utilized, including academic research, environmental monitoring, and food safety testing. Each of these applications requires specific assay methodologies tailored to their unique sample types and quantification needs. The increasing focus on environmental sustainability and food safety has fostered a growing interest in protein assays within these sectors, propelling market growth. Additionally, the expansion of research initiatives aimed at exploring novel protein functions and interactions is expected to further fuel the demand for protein assay kits across various applications.

By Distribution Channel

Online Sales:

The online sales channel has emerged as a prominent avenue for the distribution of protein assay kits, driven by the growing e-commerce landscape and changing consumer preferences. Researchers and laboratory personnel appreciate the convenience of purchasing products online, allowing them to compare options, read reviews, and often find better pricing. Additionally, online platforms provide access to a broader range of products and suppliers than traditional sales channels, making it easier for laboratories to procure specialized assay kits. The COVID-19 pandemic has further accelerated the shift toward online purchasing, and this trend is expected to continue, leading to significant growth in online sales of protein assay kits.

Direct Sales:

Direct sales refer to the distribution of protein assay kits through dedicated sales teams from manufacturers. This channel allows companies to establish direct relationships with their customers, ensuring personalized service and tailored solutions to meet specific laboratory needs. Direct sales are particularly effective in the context of large-scale laboratory setups or institutions requiring customized products. The ongoing emphasis on customer service and technical support in the life sciences sector has bolstered the importance of direct sales as a viable distribution strategy for protein assay kits.

Distributor Sales:

Distributor sales involve third-party suppliers that act as intermediaries between manufacturers and end-users. These distributors often have established networks and relationships within specific regions or sectors, enabling them to efficiently market and sell protein assay kits. The distributor model allows manufacturers to expand their reach and tap into new markets without the need for extensive investment in sales infrastructure. As the protein assay kits market continues to grow, the role of distributors is expected to remain significant, helping to streamline product availability and enhance accessibility for laboratories around the world.

Retail Sales:

Retail sales of protein assay kits are less common compared to other distribution channels, but they still represent an essential segment of the market, especially for smaller laboratories or educational institutions. Retail outlets and specialty stores may offer a selection of popular assay kits for immediate purchase, catering to users who require quick access to these products. The retail sales channel is particularly relevant in regions with emerging markets where online purchasing may not be as prevalent. As the demand for protein assay kits continues to rise, retail sales can play a complementary role in distributing these critical laboratory tools.

Others:

This category includes various alternative distribution methods not covered in the previous segments, such as collaborations with academic institutions or specialized biotech incubators. These channels may involve unique purchasing arrangements, such as bulk acquisitions for research projects or educational programs. The diversification of distribution channels reflects the evolving nature of the protein assay kits market and the need for adaptability in reaching diverse customer segments. The rise of custom assay development and personalized service offerings is expected to further expand this category over the next few years.

By Sample Type

Blood:

Blood samples are a primary type used in protein assays due to their rich information content regarding health status and disease presence. Protein assays applied to blood samples can help quantify specific proteins such as antibodies or biomarkers that indicate disease progression or therapeutic response. The increasing prevalence of chronic diseases and the growing demand for routine blood testing are driving the use of protein assay kits tailored for blood samples. Furthermore, developments in blood collection technologies and the establishment of centralized laboratories are enhancing the efficiency of protein analysis in clinical settings.

Urine:

Urine samples are commonly used in protein assays due to their non-invasive nature and ease of collection. Analyzing urine for protein content can provide critical insights into kidney function and the presence of certain diseases. The utilization of protein assays on urine samples is particularly significant in nephrology and urology, where abnormal protein levels can indicate underlying health issues. The growing awareness of the importance of urinary biomarkers in disease diagnosis and monitoring is expected to propel the demand for urine-based protein assay kits in the coming years.

Saliva:

Saliva samples are increasingly recognized for their potential in protein assays, offering a non-invasive alternative to blood testing. Salivary proteins can serve as biomarkers for various conditions, including hormonal levels, infections, and systemic diseases. The ease of sample collection and the growing trend of point-of-care testing are encouraging researchers and clinicians to explore saliva as a viable sample type for protein assays. As technology advances and the understanding of salivary biomarkers expands, the adoption of saliva-based protein assay kits is expected to grow substantially.

Tissue Homogenates:

Tissue homogenates represent a critical sample type for protein assays, especially in research settings focused on cellular mechanisms and disease pathology. Analyzing proteins within tissue samples provides essential information regarding tissue integrity, cellular function, and disease states. The use of protein assay kits for tissue homogenates is prevalent in areas such as cancer research, where the quantification of specific proteins can shed light on tumor behavior and treatment responses. As the demand for proteomic studies continues to rise, the need for robust tissue-based protein assays will remain a significant driver in the market.

Others:

This category includes various sample types that may not fit into the traditional classifications, such as environmental samples, food products, or specialized clinical samples. Each of these sample types may require specific assay methodologies adapted to their unique characteristics. The increasing focus on food safety and environmental monitoring is driving the exploration of protein assays in these areas, expanding the market for protein assay kits beyond conventional laboratory applications. As researchers seek to quantify proteins in diverse sample types, the demand for specialized assay kits will continue to grow.

By Region

The North American region is anticipated to dominate the global Protein Assay Kits market, accounting for approximately 40% of the total market share. This dominance can be attributed to the presence of advanced healthcare infrastructure, a strong emphasis on research and development, and a high concentration of key market players in the region. The U.S. is a significant contributor to this growth, driven by substantial investments in biotechnology and pharmaceutical research. Furthermore, the increasing prevalence of chronic diseases and the corresponding need for diagnostic tools are expected to bolster market growth in this region. North America is estimated to witness a CAGR of around 7.2% during the forecast period, reflecting the ongoing advancements in life sciences and healthcare.

In Europe, the Protein Assay Kits market is also expected to witness substantial growth, fueled by increasing research activities and rising healthcare expenditures. The region is characterized by a robust academic and research landscape, with numerous universities and institutions engaged in life sciences research. Countries such as Germany, France, and the UK are key players in the European market, contributing significantly to the demand for protein assay kits. Additionally, the growing focus on personalized medicine and the development of innovative diagnostic solutions are expected to drive the market's expansion in Europe. The region is projected to see a CAGR of approximately 6.8% during the forecast period, indicating a strong potential for growth in the coming years.

Opportunities

The Protein Assay Kits market presents numerous opportunities for growth driven by technological advancements and increasing research funding. As the life sciences industry continues to innovate, there is potential for the development of next-generation protein assay kits that offer enhanced sensitivity, specificity, and ease of use. The integration of automation and high-throughput capabilities into protein assays is particularly promising, as it allows laboratories to process a larger number of samples with greater efficiency. Furthermore, as the understanding of proteomics and its implications in personalized medicine deepens, the demand for specialized protein assays tailored to specific diseases and patient profiles is expected to rise. This presents a significant opportunity for manufacturers to develop niche products that cater to the evolving needs of researchers and clinicians.

Additionally, the increasing emphasis on regulatory compliance and quality control in the biopharmaceutical industry is driving demand for protein assay kits that meet stringent standards. As the industry expands, there is a growing need for reliable and validated assay methods to ensure the accuracy and reproducibility of results. This trend presents a lucrative opportunity for companies to invest in the development of assay kits that comply with regulatory requirements and provide high-quality data. The rise of collaborations between academic institutions and industry players is also fostering innovation and accelerating the development of novel protein assays, further enhancing market opportunities. Overall, the Protein Assay Kits market is well-positioned to capitalize on these trends, leading to sustained growth over the coming decade.

Threats

Despite the promising growth prospects for the Protein Assay Kits market, there are several threats that could hinder its advancement. One of the primary concerns is the increasing competition within the market, as numerous players strive to capture market share through product differentiation and innovation. This heightened competition may lead to price wars, eroding profit margins for manufacturers and resulting in a challenging landscape for new entrants. Additionally, the rapid pace of technological advancements could render existing products obsolete if companies fail to keep up with the latest trends and innovations. The constant pressure to innovate may strain resources and divert attention from other critical business aspects.

Another potential threat to the market is the changing regulatory landscape surrounding diagnostic and research products. As regulatory bodies continue to impose stricter guidelines on product quality and efficacy, companies may face challenges in obtaining necessary approvals and certifications for their protein assay kits. This could lead to delays in product launches and increased costs associated with compliance efforts. Furthermore, the global economic uncertainties, exacerbated by events such as the COVID-19 pandemic, may impact research funding and laboratory budgets, potentially constraining the demand for protein assay kits. Companies must remain vigilant and adaptable to navigate these threats effectively and sustain their growth in the competitive protein assay market.

Competitor Outlook

• Thermo Fisher Scientific
• Bio-Rad Laboratories
• Abcam Plc
• MilliporeSigma (Merck KGaA)
• Roche Diagnostics
• PerkinElmer, Inc.
• Promega Corporation
• Waters Corporation
• Enzo Life Sciences
• Cell Signaling Technology
• Santa Cruz Biotechnology
• Biovision Inc.
• Fisher Scientific
• QuantiBio
• Analytik Jena AG

The Protein Assay Kits market is characterized by a competitive landscape featuring a variety of established players and emerging companies. Major companies such as Thermo Fisher Scientific, Bio-Rad Laboratories, and Abcam Plc dominate the market, leveraging their extensive product portfolios and strong distribution networks to maintain a competitive edge. These firms invest heavily in research and development to introduce innovative protein assay solutions that meet the evolving needs of researchers and clinicians. Additionally, strategic collaborations and partnerships are common in this industry, as companies seek to enhance their capabilities and expand their market reach through synergies with other players.

Thermo Fisher Scientific is a leading player in the protein assay kits market, known for its comprehensive range of products and services tailored to various research applications. The company emphasizes innovation and quality, frequently launching new assays that cater to specific research needs. Bio-Rad Laboratories is another prominent competitor renowned for its focus on high-quality reagents and instruments for protein analysis. Their commitment to advancing life sciences research is reflected in their continued investment in product development and strategic acquisitions. Abcam Plc stands out for its extensive catalog of antibodies and protein assays, positioning itself as a go-to supplier for researchers across multiple fields.

Emerging companies also play a role in shaping the competitive landscape of the Protein Assay Kits market. Many start-ups are focusing on niche products or innovative technologies that address specific challenges in protein analysis, providing opportunities for collaboration with larger firms seeking to enhance their offerings. The market's dynamic nature calls for continuous adaptation as companies strive to keep pace with technological advancements and changing customer preferences. Overall, the competitive landscape is expected to evolve, providing a fertile ground for innovation and growth within the protein assay kits market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Abcam Plc
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 QuantiBio
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Biovision Inc.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Analytik Jena AG
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Fisher Scientific
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 PerkinElmer, Inc.
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Roche Diagnostics
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Enzo Life Sciences
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Waters Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Promega Corporation
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Bio-Rad Laboratories
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Santa Cruz Biotechnology
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Thermo Fisher Scientific
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Cell Signaling Technology
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 MilliporeSigma (Merck KGaA)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Protein Assay Kits Sales Market, By Application
    • 6.1.1 Drug Discovery & Development
    • 6.1.2 Disease Diagnosis
    • 6.1.3 Protein Purification
    • 6.1.4 Others
  • 6.2 Protein Assay Kits Sales Market, By Sample Type
    • 6.2.1 Blood
    • 6.2.2 Urine
    • 6.2.3 Saliva
    • 6.2.4 Tissue Homogenates
    • 6.2.5 Others
  • 6.3 Protein Assay Kits Sales Market, By Product Type
    • 6.3.1 Dye-binding Assay Kits
    • 6.3.2 Copper-Ion Based Assay Kits
    • 6.3.3 Test Strip/ Dipstick Assay Kits
    • 6.3.4 Colorimetric Assay Kits
    • 6.3.5 Fluorescence-based Assay Kits
  • 6.4 Protein Assay Kits Sales Market, By Distribution Channel
    • 6.4.1 Online Sales
    • 6.4.2 Direct Sales
    • 6.4.3 Distributor Sales
    • 6.4.4 Retail Sales
    • 6.4.5 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Protein Assay Kits Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Protein Assay Kits Sales market is categorized based on

By Product Type

• Dye-binding Assay Kits
• Copper-Ion Based Assay Kits
• Test Strip/ Dipstick Assay Kits
• Colorimetric Assay Kits
• Fluorescence-based Assay Kits

By Application

• Drug Discovery & Development
• Disease Diagnosis
• Protein Purification
• Others

By Distribution Channel

• Online Sales
• Direct Sales
• Distributor Sales
• Retail Sales
• Others

By Sample Type

• Blood
• Urine
• Saliva
• Tissue Homogenates
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Thermo Fisher Scientific
• Bio-Rad Laboratories
• Abcam Plc
• MilliporeSigma (Merck KGaA)
• Roche Diagnostics
• PerkinElmer, Inc.
• Promega Corporation
• Waters Corporation
• Enzo Life Sciences
• Cell Signaling Technology
• Santa Cruz Biotechnology
• Biovision Inc.
• Fisher Scientific
• QuantiBio
• Analytik Jena AG